Join to access to all OVN content. Join for Free
Using Your VOICE as a Weapon
voice training vocal presence professional settings emotional connections vocal skills

Using Your VOICE as a Weapon


Share This Article


Summary

In this episode, Tom Caravela is joined by Matt Berthot to explore the significance of voice training in professional settings. Matt shares insights into his career journey and the importance of vocal presence in medical affairs. The discussion covers practical tips for enhancing vocal skills and overcoming fear, emphasizing the role of voice in building emotional connections and expressing emotions effectively in business. Matt provides strategies for preparing emotionally and mentally for meetings, highlighting the interplay between voice mechanics and emotional impact. The episode wraps up with advice on cultivating emotional resonance and where to connect with Matt online.

Matt Berthot, Vocal Coach and CEO at Voice by Matt LLC, discusses how to use your voice as a weapon.

Matt shares….

πŸ‘‰ What a voice coach does and how it differs from what you might think
πŸ‘‰ The importance of transferring energy
πŸ‘‰ What it means to be authentic and share your REAL voice
πŸ‘‰ How to show your soul

Click for Source
voice training, vocal presence, professional settings, emotional connections, vocal skills

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Explore OVN